Literature DB >> 24216301

Evaluation of simple in vitro to in vivo extrapolation approaches for environmental compounds.

Miyoung Yoon1, Alina Efremenko2, Bas J Blaauboer3, Harvey J Clewell2.   

Abstract

As part of an effort to support in silico/in vitro based risk assessment, we evaluated the accuracy associated with conducting simple in vitro to in vivo extrapolation (IVIVE) for environmental compounds using available in vitro human metabolism data. The IVIVE approach was applied to a number of compounds with a wide range of properties spanning the diversity of characteristics of environmental compounds, and where possible the resulting estimates of the in vivo steady-state blood concentration were compared with estimates derived on the basis of human in vivo kinetic data. There appears to be a systematic bias in the estimation of intrinsic clearance (Clint) from in vitro versus in vivo data, with in vitro based estimates underestimating in vivo clearance for small values of Clint but with the opposite relationship at large values of Clint. Nevertheless, the resulting estimates of Css were in good agreement. The chief drawback of the simple approach used in this study, which performs the IVIVE prediction for the parent compound only, is that it is not applicable for toxicity associated with a metabolite.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C(ss); IVIVE; In vitro metabolism; Reverse dosimetry

Mesh:

Substances:

Year:  2013        PMID: 24216301     DOI: 10.1016/j.tiv.2013.10.023

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  17 in total

1.  Toxicokinetic Triage for Environmental Chemicals.

Authors:  John F Wambaugh; Barbara A Wetmore; Robert Pearce; Cory Strope; Rocky Goldsmith; James P Sluka; Alexander Sedykh; Alex Tropsha; Sieto Bosgra; Imran Shah; Richard Judson; Russell S Thomas; R Woodrow Setzer
Journal:  Toxicol Sci       Date:  2015-06-16       Impact factor: 4.849

Review 2.  Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.

Authors:  Corie A Ellison; Karen L Blackburn; Paul L Carmichael; Harvey J Clewell; Mark T D Cronin; Bertrand Desprez; Sylvia E Escher; Steve S Ferguson; Sébastien Grégoire; Nicola J Hewitt; Heli M Hollnagel; Martina Klaric; Atish Patel; Sabrina Salhi; Andreas Schepky; Barbara G Schmitt; John F Wambaugh; Andrew Worth
Journal:  Regul Toxicol Pharmacol       Date:  2019-01-15       Impact factor: 3.271

Review 3.  In vitro to in vivo extrapolation for high throughput prioritization and decision making.

Authors:  Shannon M Bell; Xiaoqing Chang; John F Wambaugh; David G Allen; Mike Bartels; Kim L R Brouwer; Warren M Casey; Neepa Choksi; Stephen S Ferguson; Grazyna Fraczkiewicz; Annie M Jarabek; Alice Ke; Annie Lumen; Scott G Lynn; Alicia Paini; Paul S Price; Caroline Ring; Ted W Simon; Nisha S Sipes; Catherine S Sprankle; Judy Strickland; John Troutman; Barbara A Wetmore; Nicole C Kleinstreuer
Journal:  Toxicol In Vitro       Date:  2017-12-05       Impact factor: 3.500

4.  Polymeric Nanoparticles Controlled by On-Chip Self-Assembly Enhance Cancer Treatment Effectiveness.

Authors:  Sungjin Jung; Junseok Lee; Junha Lim; Jeeyeon Suh; Taeyoung Kim; Jungho Ahn; Won Jong Kim; YongTae Kim
Journal:  Adv Healthc Mater       Date:  2020-10-18       Impact factor: 9.933

5.  Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics.

Authors:  John F Wambaugh; Michael F Hughes; Caroline L Ring; Denise K MacMillan; Jermaine Ford; Timothy R Fennell; Sherry R Black; Rodney W Snyder; Nisha S Sipes; Barbara A Wetmore; Joost Westerhout; R Woodrow Setzer; Robert G Pearce; Jane Ellen Simmons; Russell S Thomas
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

6.  Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization.

Authors:  John F Wambaugh; Barbara A Wetmore; Caroline L Ring; Chantel I Nicolas; Robert G Pearce; Gregory S Honda; Roger Dinallo; Derek Angus; Jon Gilbert; Teresa Sierra; Akshay Badrinarayanan; Bradley Snodgrass; Adam Brockman; Chris Strock; R Woodrow Setzer; Russell S Thomas
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

7.  Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays.

Authors:  Jeremy A Leonard; Ashley Sobel Leonard; Daniel T Chang; Stephen Edwards; Jingtao Lu; Steven Scholle; Phillip Key; Maxwell Winter; Kristin Isaacs; Yu-Mei Tan
Journal:  Environ Sci Technol       Date:  2016-05-12       Impact factor: 9.028

8.  Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

Authors:  Katie Paul Friedman; Matthew Gagne; Lit-Hsin Loo; Panagiotis Karamertzanis; Tatiana Netzeva; Tomasz Sobanski; Jill A Franzosa; Ann M Richard; Ryan R Lougee; Andrea Gissi; Jia-Ying Joey Lee; Michelle Angrish; Jean Lou Dorne; Stiven Foster; Kathleen Raffaele; Tina Bahadori; Maureen R Gwinn; Jason Lambert; Maurice Whelan; Mike Rasenberg; Tara Barton-Maclaren; Russell S Thomas
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

9.  A Liver-Centric Multiscale Modeling Framework for Xenobiotics.

Authors:  James P Sluka; Xiao Fu; Maciej Swat; Julio M Belmonte; Alin Cosmanescu; Sherry G Clendenon; John F Wambaugh; James A Glazier
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

10.  Correlation of In Vivo Versus In Vitro Benchmark Doses (BMDs) Derived From Micronucleus Test Data: A Proof of Concept Study.

Authors:  Lya G Soeteman-Hernández; Mick D Fellows; George E Johnson; Wout Slob
Journal:  Toxicol Sci       Date:  2015-10-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.